Novel vaccine approaches for protection against intracellular pathogens.
about
Post-Genomics and Vaccine Improvement for LeishmaniaNeonatal Vaccination: Challenges and Intervention StrategiesTargeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacyAIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.Vaccine adjuvant materials for cancer immunotherapy and control of infectious diseaseNeutrophils Contribute to the Protection Conferred by ArtinM against Intracellular Pathogens: A Study on Leishmania major.Structure and Function of HLA-A*02-Restricted Hantaan Virus Cytotoxic T-Cell Epitope That Mediates Effective Protective Responses in HLA-A2.1/K(b) Transgenic Mice.Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach.Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice.CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway.Listening to each other: Infectious disease and cancer immunology.A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.CD14 is critical for TLR2-mediated M1 macrophage activation triggered by N-glycan recognition.Rationalized design of a mucosal vaccine protects against Mycobacterium tuberculosis challenge in mice.Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge.Mycobacterium tuberculosis HspX/EsxS Fusion Protein: Gene Cloning, Protein Expression, and Purification in Escherichia coli.Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.
P2860
Q26752532-A9D2377B-E0B7-40D1-A2CE-87D8FD403C5DQ28066069-3DDDAF57-B454-4DB3-A93B-FF17C02D23DBQ28354371-7DAC95D7-E34B-4815-84B9-BB49C9EA8C02Q33774747-9076C525-DFED-4E98-985A-EA430CAD6D1AQ35035612-3477DBA4-DD29-44E5-90A8-6721D1E6A8DDQ35983573-B0197745-D572-41F6-918B-5E64C9392973Q37157256-3F09B295-C851-47DF-A722-A643E7EDA9BAQ37546883-DA517E41-AAD9-45CF-9571-F724634C8458Q38364597-CA106107-D9D5-4F82-A68A-1DE98EAE1DD3Q38740356-56D01CA5-8EAE-42FB-953D-79ADF7517B84Q40085228-ECD0CE1E-F8CD-42B4-950E-216A12BBB6D2Q40103816-3063599C-C9A4-4B3B-A04C-152CA26F01D3Q40107672-538BFFEB-5F2E-4A72-B80A-9DA6266267FCQ40110484-06BEF296-E0D0-4765-B784-4BE4BA73B18AQ40309267-155D934B-BD10-4B00-9F15-9902B3104540Q41335764-0E83AFF7-EC12-4300-8D94-3BABF323FA61Q41517191-EFB25B54-B249-4041-9397-3EB31E6F1277Q42694439-0D6F30AE-75CF-4336-9A9D-D61C284FF916Q48343602-4886401D-4C7C-41C3-B7AC-30A7FA18250D
P2860
Novel vaccine approaches for protection against intracellular pathogens.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel vaccine approaches for protection against intracellular pathogens.
@en
type
label
Novel vaccine approaches for protection against intracellular pathogens.
@en
prefLabel
Novel vaccine approaches for protection against intracellular pathogens.
@en
P2860
P1476
Novel vaccine approaches for protection against intracellular pathogens
@en
P2093
Shabaana A Khader
P2860
P356
10.1016/J.COI.2014.02.003
P577
2014-03-06T00:00:00Z